Skip to main content

FoundayoEli LillySide Effects & Safety Profile

What to expect, how to manage, and when to call your doctor

What You Need to Know

Most Common Side Effects

MOST COMMON
Nausea 29-36%
vs 10% placebo
SERIOUS EVENTS
Rare (< 1%)
Pancreatitis, gallbladder events
DISCONTINUATION
5-10% stopped early
vs 2.7% placebo
TIMING
Improve by 4-8 weeks
Peak during dose escalation

What the ATTAIN-1 Trial Shows

Side Effects by Dose

About the data: The ATTAIN-1 trial tested three doses (6mg, 12mg, 36mg) against placebo over 72 weeks. Higher doses showed slightly higher side effect rates but also more weight loss. Commercial doses (0.8-17.2mg) allow for more gradual titration.

Side Effect6 mg12 mg36 mgPlacebo
Nausea28.9%35.9%33.7%10.4%
Vomiting13.0%21.4%24.0%3.5%
Diarrhea21.0%22.8%23.1%9.6%
Constipation21.7%29.8%25.4%9.3%
Discontinued due to AEs5.3%7.9%10.3%2.7%

Source: ATTAIN-1 trial (NEJM, September 2025)[1]

Why They Happen and How to Manage

GI Side Effects

Why These Side Effects Occur

Foundayo is a GLP-1 receptor agonist. GLP-1 slows gastric emptying (how fast food leaves your stomach), which helps you feel full longer—but also causes the GI side effects. The good news: your body adapts over time, and most symptoms improve within 4-8 weeks.

Nausea

Frequency:29-36%vs 10% placebo

Vomiting

Frequency:13-24%vs 3.5% placebo

Diarrhea

Frequency:21-23%vs 9.6% placebo

Constipation

Frequency:22-30%vs 9.3% placebo

Events Requiring Immediate Attention

Serious Side Effects and Warnings

Overall Safety: Serious adverse events were rare in the ATTAIN-1 trial. However, certain events require immediate medical attention if they occur. Know these warning signs.

Acute Pancreatitis

Risk: Rare but monitored with all GLP-1 receptor agonists

Symptoms:

  • Severe abdominal pain (may radiate to back)
  • Nausea and vomiting
  • Fever
  • Rapid pulse

Action: STOP MEDICATION and seek immediate medical attention

Acute Kidney Injury

Risk: Can occur with dehydration from GI side effects (vomiting, diarrhea)

Symptoms:

  • Decreased urination
  • Swelling in legs or ankles
  • Fatigue or confusion
  • Shortness of breath

Prevention: Stay well-hydrated, especially if experiencing GI symptoms

Action: Contact your doctor if you experience these symptoms

Gallbladder Disease

Risk: Increased with rapid weight loss (not unique to Foundayo)

Symptoms:

  • Right upper abdominal pain
  • Nausea after fatty meals
  • Yellowing of skin or eyes (jaundice)
  • Fever

Action: Contact doctor promptly if symptoms develop

Hypoglycemia (Low Blood Sugar)

Risk: Primarily when combined with insulin or sulfonylureas

Symptoms:

  • Shakiness, sweating
  • Rapid heartbeat
  • Confusion, dizziness
  • Hunger

Prevention: Your doctor may reduce insulin/sulfonylurea doses when starting Foundayo

Action: Treat with fast-acting carbs (juice, glucose tablets); call doctor if frequent

Severe Allergic Reactions

Risk: Rare

Symptoms:

  • Swelling of face, lips, tongue, throat
  • Difficulty breathing
  • Severe rash or hives
  • Rapid pulse, dizziness

Action: Call 911 or seek emergency care immediately

Understanding the Black Box Warning

Thyroid Cancer Risk

Medullary Thyroid Carcinoma (MTC) Warning

What it means: The FDA requires a "black box warning" about the risk of thyroid tumors (specifically MTC) for all GLP-1 receptor agonists. This is based on studies in rodents—the relevance to humans is unclear, but caution is warranted.

Who should NOT take Foundayo:

  • Personal history of medullary thyroid carcinoma (MTC)
  • Family history of MTC
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Symptoms to watch for:

  • Lump or swelling in neck
  • Hoarseness
  • Trouble swallowing
  • Shortness of breath

What to do: Discuss your family history of thyroid cancer with your doctor before starting Foundayo. Report any thyroid-related symptoms immediately.

Contraindications and Precautions

Who Should Not Take Foundayo

Do NOT Use Foundayo If You Have:

  • Personal history of medullary thyroid carcinoma (MTC)
  • Family history of medullary thyroid carcinoma
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Known hypersensitivity to orforglipron or any ingredients

Use with Caution (Discuss with Doctor):

  • History of pancreatitis
  • Gallbladder disease or gallstones
  • Severe gastrointestinal disease (gastroparesis, IBD)
  • History of diabetic retinopathy (monitor closely)
  • Kidney disease
  • Taking insulin or sulfonylureas (hypoglycemia risk)
  • Pregnancy or breastfeeding

Pregnancy: Discontinue Foundayo at least 2 months before a planned pregnancy. Weight loss during pregnancy can harm the fetus. Lilly is establishing a pregnancy registry to monitor outcomes.

Side Effect Comparison

Foundayo vs Other GLP-1s

The Bottom Line

Foundayo has a similar side effect profile to other GLP-1 medications. The main differences are in convenience, not tolerability. All GLP-1s cause GI side effects—it's how they work.

FeatureFoundayoOral WegovyInjectable GLP-1s
Nausea rate29-36%~20-35%~20-40%
Discontinuation rate5-10%~5-7%~5-10%
Injection site reactionsNone (pill)None (pill)~5-10%
Food restrictionsNONE30-min fastingNone
Dosing flexibilityAny time of dayMorning onlyAny time

Foundayo's advantage: If you experience nausea in the morning, you can simply take Foundayo at night instead. With Oral Wegovy, you're locked into a strict morning routine with 30 minutes of fasting. This flexibility can make side effects more manageable.

Want a detailed comparison? See our guides: Foundayo vs Wegovy | Foundayo vs Zepbound

Practical Tips That Work

Managing Side Effects

Start Low, Go Slow

  • Start at the lowest dose (0.8 mg) and increase gradually
  • Allow 4 weeks at each dose before increasing
  • Don't rush to higher doses—find your optimal balance
  • Talk to your doctor about slower escalation if symptoms are severe

Timing Flexibility (Foundayo Advantage)

  • Unlike Oral Wegovy, Foundayo has NO food restrictions
  • Take any time of day—morning, afternoon, or evening
  • If morning nausea is an issue, try taking it at bedtime
  • Take with or without food—whatever works for you

Dietary Modifications

  • Eat smaller, more frequent meals (5-6 small meals vs 3 large)
  • Avoid high-fat, greasy, fried foods (worsen nausea)
  • Limit spicy foods and caffeine
  • Eat slowly and chew thoroughly
  • Stop eating when comfortably full (not stuffed)

Stay Hydrated

  • Drink 8-10 glasses of water daily
  • Sip fluids throughout the day (not large amounts at once)
  • Electrolyte drinks if experiencing diarrhea or vomiting
  • Hydration helps prevent kidney issues and eases constipation

Symptom-Specific Remedies

  • Nausea: Ginger tea, peppermint, anti-nausea medications if prescribed
  • Diarrhea: BRAT diet, loperamide if severe, probiotics
  • Constipation: Increase fiber gradually, stool softeners, hydration
  • Heartburn: Avoid triggers, elevate head when sleeping, antacids

Warning Signs That Need Attention

When to Call Your Doctor

Call 911 or Go to ER Immediately:

  • Severe allergic reaction (swelling of face/throat, difficulty breathing)
  • Severe abdominal pain that doesn't go away (possible pancreatitis)
  • Signs of severe dehydration (confusion, fainting, very dark urine)

Call Your Doctor Same Day:

  • Vomiting that prevents you from keeping fluids down
  • Severe diarrhea (6+ loose stools per day)
  • Blood in vomit or stool
  • Yellowing of skin or eyes (jaundice)
  • Signs of hypoglycemia that don't resolve with treatment
  • Lump or swelling in your neck

Schedule an Appointment (Within a Week):

  • Side effects that don't improve after 2-3 weeks
  • Persistent constipation or diarrhea
  • Headaches that don't respond to over-the-counter medications
  • Concerns about tolerability or whether to continue
FOUNDAYO SIDE EFFECTS QUESTIONS

FAQs

Yes, Foundayo was FDA-approved on April 1, 2026 after rigorous Phase 3 clinical trials. The ATTAIN program studied orforglipron across multiple trials with thousands of participants. The most common side effects are gastrointestinal (nausea, diarrhea, constipation) and are typically mild to moderate. About 90% of patients tolerated Foundayo well enough to continue treatment in ATTAIN-1.
Hair loss (telogen effluvium) can occur with any rapid weight loss, regardless of how you lose the weight. It's not specific to Foundayo or GLP-1 medications. This type of hair loss is usually temporary and resolves once your weight stabilizes. If you experience significant hair loss, discuss it with your doctor.
Most gastrointestinal side effects (nausea, diarrhea, constipation) peak during the first 4-8 weeks of treatment and during dose escalation. As your body adjusts to the medication, these symptoms typically improve significantly. If side effects persist beyond 8 weeks or worsen, contact your doctor.
Yes, but use caution with insulin or sulfonylureas, as combining them with Foundayo increases the risk of hypoglycemia (low blood sugar). Your doctor may need to reduce your insulin or sulfonylurea dose when you start Foundayo. Monitor your blood sugar closely, especially during the first few weeks.
Moderate alcohol consumption is generally acceptable while taking Foundayo. However, alcohol may worsen nausea and other GI side effects. There's no specific prohibition, but discuss your alcohol use with your doctor, especially if you experience significant side effects.
Like all GLP-1 receptor agonists, Foundayo carries a black box warning about the risk of medullary thyroid carcinoma (MTC). This is based on rodent studies; the relevance to humans is unclear. Foundayo should NOT be used by anyone with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Pancreatitis is a rare but monitored risk with all GLP-1 medications. In clinical trials, pancreatitis was uncommon. If you experience severe, persistent abdominal pain (especially pain that radiates to your back), stop taking Foundayo and seek immediate medical attention.
No. Foundayo has a similar side effect profile to other GLP-1 receptor agonists like Wegovy, Ozempic, and Zepbound. All GLP-1 medications primarily cause GI side effects because of how they work (slowing gastric emptying). The advantage of Foundayo is that it's a pill with no food restrictions, so you have more flexibility in managing side effects (e.g., taking it at different times of day).

Compare GLP-1 Options

See how Foundayo compares to other weight loss medications

Sources

References

  1. Wharton S, et al. "Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment." N Engl J Med. 2025 Nov 6;393(18):1796-1806. doi: 10.1056/NEJMoa2511774. Epub 2025 Sep 16. PubMed
  2. FDA. "FDA approves Foundayo (orforglipron) for chronic weight management." FDA News Release. April 1, 2026.
  3. Eli Lilly and Company. "Foundayo (orforglipron) Prescribing Information." April 2026. Full Prescribing Information
  4. Eli Lilly and Company. "FDA approves Lilly's Foundayo (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day." PR Newswire. April 1, 2026.

Reviewed by Honest Care GLP-1 SpecialistsLast updated October 6, 2026

Ready to Get Started with Foundayo?

If you're considering Foundayo, we can help you navigate insurance coverage. Our specialists have helped patients successfully appeal denials—many appeals succeed when properly documented with medical necessity evidence.

Check Your Coverage Options

Disclaimer

The information on this page is for educational and informational purposes only and is not intended as medical advice. Honest Care does not provide medical diagnosis, treatment, or individualized recommendations. Always seek the advice of your physician or other qualified healthcare professional regarding any medical condition or treatment.

While this content has been reviewed for accuracy and balance, new evidence may emerge after publication. Drug availability, indications, and insurance coverage can change over time. Honest Care makes no warranties as to completeness or currentness of the information and is not responsible for decisions made based on this content.